Product Code: TMRGL42137
The report provides revenue of the global infusion therapy market for the period 2017-2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global infusion therapy market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the infusion therapy market.
The report delves into the competitive landscape of the global infusion therapy market. Key players operating in the global infusion therapy market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global infusion therapy market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Infusion Therapy Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Segment Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Porter's Five Force Analysis
5. Key Insights
- 5.1. Key Industry Developments
- 5.2. Disease Prevalence & Incidence Rate globally with key countries
- 5.3. Technological Advancements
- 5.4. Regulatory Scenario by Region/globally
- 5.5. Covid-19 Pandemic impact on the industry
6. Global Infusion Therapy Market Analysis and Forecast, by Product
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Infusion Pumps
- 6.3.1.1. Ambulatory Infusion Pumps
- 6.3.1.2. Stationary Infusion Pumps
- 6.3.1.3. Syringe Infusion Pumps
- 6.3.1.4. Disposable Pumps
- 6.3.1.5. Large Volume Pumps
- 6.3.1.6. Elastomeric Pumps
- 6.3.2. Infusion Set
- 6.3.3. Accessories
- 6.4. Market Attractiveness Analysis, by Product
7. Global Infusion Therapy Market Analysis and Forecast, by Indication
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Indication, 2017-2031
- 7.3.1. Cancer
- 7.3.2. Gastrointestinal Diseases / Disorders
- 7.3.3. Congestive Heart Failure
- 7.3.4. Rheumatoid Arthritis
- 7.3.5. Hemophilia
- 7.3.6. Immune Deficiencies
- 7.3.7. Others
- 7.4. Market Attractiveness Analysis, by Indication
8. Global Infusion Therapy Market Analysis and Forecast, by Therapy Type
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by Therapy Type, 2017-2031
- 8.3.1. Antibiotic/Antiviral
- 8.3.2. Anti-coagulation
- 8.3.3. Anti-emetics
- 8.3.4. Blood Component Stimulating Factor
- 8.3.5. Chemotherapy
- 8.3.6. Nutrition
- 8.3.7. Hydration
- 8.3.8. Pain Management
- 8.4. Market Attractiveness Analysis, by Therapy Type
9. Global Infusion Therapy Market Analysis and Forecast, by End-user
- 9.1. Introduction & Definition
- 9.2. Key Findings / Developments
- 9.3. Market Value Forecast, by End-user, 2017-2031
- 9.3.1. Hospitals
- 9.3.2. Ambulatory Surgical Centers
- 9.3.3. Clinics
- 9.3.4. Homecare Settings
- 9.4. Market Attractiveness Analysis, by End-user
10. Global Infusion Therapy Market Analysis and Forecast, by Region
- 10.1. Key Findings
- 10.2. Market Value Forecast, by Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
- 10.3. Market Attractiveness Analysis, by Region
11. North America Infusion Therapy Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Product, 2017-2031
- 11.2.1. Infusion Pumps
- 11.2.1.1. Ambulatory Infusion Pumps
- 11.2.1.2. Stationary Infusion Pumps
- 11.2.1.3. Syringe Infusion Pumps
- 11.2.1.4. Disposable Pumps
- 11.2.1.5. Large Volume Pumps
- 11.2.1.6. Elastomeric Pumps
- 11.2.2. Infusion Set
- 11.2.3. Accessories
- 11.3. Market Value Forecast, by Indication, 2017-2031
- 11.3.1. Cancer
- 11.3.2. Gastrointestinal Diseases / Disorders
- 11.3.3. Congestive Heart Failure
- 11.3.4. Rheumatoid Arthritis
- 11.3.5. Hemophilia
- 11.3.6. Immune Deficiencies
- 11.3.7. Others
- 11.4. Market Value Forecast, by Therapy Type, 2017-2031
- 11.4.1. Antibiotic/Antiviral
- 11.4.2. Anti-coagulation
- 11.4.3. Anti-emetics
- 11.4.4. Blood Component Stimulating Factor
- 11.4.5. Chemotherapy
- 11.4.6. Nutrition
- 11.4.7. Hydration
- 11.4.8. Pain Management
- 11.5. Market Value Forecast, by End-user, 2017-2031
- 11.5.1. Hospitals
- 11.5.2. Ambulatory Surgical Centers
- 11.5.3. Clinics
- 11.5.4. Homecare Settings
- 11.6. Market Value Forecast, by Country, 2017-2031
- 11.6.1. U.S.
- 11.6.2. Canada
- 11.7. Market Attractiveness Analysis
- 11.7.1. By Product
- 11.7.2. By Indication
- 11.7.3. By Therapy Type
- 11.7.4. By End-user
- 11.7.5. By Country
12. Europe Infusion Therapy Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. Infusion Pumps
- 12.2.1.1. Ambulatory Infusion Pumps
- 12.2.1.2. Stationary Infusion Pumps
- 12.2.1.3. Syringe Infusion Pumps
- 12.2.1.4. Disposable Pumps
- 12.2.1.5. Large Volume Pumps
- 12.2.1.6. Elastomeric Pumps
- 12.2.2. Infusion Set
- 12.2.3. Accessories
- 12.3. Market Value Forecast, by Indication, 2017-2031
- 12.3.1. Cancer
- 12.3.2. Gastrointestinal Diseases / Disorders
- 12.3.3. Congestive Heart Failure
- 12.3.4. Rheumatoid Arthritis
- 12.3.5. Hemophilia
- 12.3.6. Immune Deficiencies
- 12.3.7. Others
- 12.4. Market Value Forecast, by Therapy Type, 2017-2031
- 12.4.1. Antibiotic/Antiviral
- 12.4.2. Anti-coagulation
- 12.4.3. Anti-emetics
- 12.4.4. Blood Component Stimulating Factor
- 12.4.5. Chemotherapy
- 12.4.6. Nutrition
- 12.4.7. Hydration
- 12.4.8. Pain Management
- 12.5. Market Value Forecast, by End-user, 2017-2031
- 12.5.1. Hospitals
- 12.5.2. Ambulatory Surgical Centers
- 12.5.3. Clinics
- 12.5.4. Homecare Settings
- 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.6.1. Germany
- 12.6.2. U.K.
- 12.6.3. France
- 12.6.4. Italy
- 12.6.5. Spain
- 12.6.6. Rest of Europe
- 12.7. Market Attractiveness Analysis
- 12.7.1. By Product
- 12.7.2. By Indication
- 12.7.3. By Therapy Type
- 12.7.4. By End-user
- 12.7.5. By Country/Sub-region
13. Asia Pacific Infusion Therapy Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. Infusion Pumps
- 13.2.1.1. Ambulatory Infusion Pumps
- 13.2.1.2. Stationary Infusion Pumps
- 13.2.1.3. Syringe Infusion Pumps
- 13.2.1.4. Disposable Pumps
- 13.2.1.5. Large Volume Pumps
- 13.2.1.6. Elastomeric Pumps
- 13.2.2. Infusion Set
- 13.2.3. Accessories
- 13.3. Market Value Forecast, by Indication, 2017-2031
- 13.3.1. Cancer
- 13.3.2. Gastrointestinal Diseases / Disorders
- 13.3.3. Congestive Heart Failure
- 13.3.4. Rheumatoid Arthritis
- 13.3.5. Hemophilia
- 13.3.6. Immune Deficiencies
- 13.3.7. Others
- 13.4. Market Value Forecast, by Therapy Type, 2017-2031
- 13.4.1. Antibiotic/Antiviral
- 13.4.2. Anti-coagulation
- 13.4.3. Anti-emetics
- 13.4.4. Blood Component Stimulating Factor
- 13.4.5. Chemotherapy
- 13.4.6. Nutrition
- 13.4.7. Hydration
- 13.4.8. Pain Management
- 13.5. Market Value Forecast, by End-user, 2017-2031
- 13.5.1. Hospitals
- 13.5.2. Ambulatory Surgical Centers
- 13.5.3. Clinics
- 13.5.4. Homecare Settings
- 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
- 13.7. Market Attractiveness Analysis
- 13.7.1. By Product
- 13.7.2. By Indication
- 13.7.3. By Therapy Type
- 13.7.4. By End-user
- 13.7.5. By Country/Sub-region
14. Latin America Infusion Therapy Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Product, 2017-2031
- 14.2.1. Infusion Pumps
- 14.2.1.1. Ambulatory Infusion Pumps
- 14.2.1.2. Stationary Infusion Pumps
- 14.2.1.3. Syringe Infusion Pumps
- 14.2.1.4. Disposable Pumps
- 14.2.1.5. Large Volume Pumps
- 14.2.1.6. Elastomeric Pumps
- 14.2.2. Infusion Set
- 14.2.3. Accessories
- 14.3. Market Value Forecast, by Indication, 2017-2031
- 14.3.1. Cancer
- 14.3.2. Gastrointestinal Diseases / Disorders
- 14.3.3. Congestive Heart Failure
- 14.3.4. Rheumatoid Arthritis
- 14.3.5. Hemophilia
- 14.3.6. Immune Deficiencies
- 14.3.7. Others
- 14.4. Market Value Forecast, by Therapy Type, 2017-2031
- 14.4.1. Antibiotic/Antiviral
- 14.4.2. Anti-coagulation
- 14.4.3. Anti-emetics
- 14.4.4. Blood Component Stimulating Factor
- 14.4.5. Chemotherapy
- 14.4.6. Nutrition
- 14.4.7. Hydration
- 14.4.8. Pain Management
- 14.5. Market Value Forecast, by End-user, 2017-2031
- 14.5.1. Hospitals
- 14.5.2. Ambulatory Surgical Centers
- 14.5.3. Clinics
- 14.5.4. Homecare Settings
- 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
- 14.7. Market Attractiveness Analysis
- 14.7.1. By Product
- 14.7.2. By Indication
- 14.7.3. By Therapy Type
- 14.7.4. By End-user
- 14.7.5. By Country/Sub-region
15. Middle East & Africa Infusion Therapy Market Analysis and Forecast
- 15.1. Introduction
- 15.2. Market Value Forecast, by Product, 2017-2031
- 15.2.1. Infusion Pumps
- 15.2.1.1. Ambulatory Infusion Pumps
- 15.2.1.2. Stationary Infusion Pumps
- 15.2.1.3. Syringe Infusion Pumps
- 15.2.1.4. Disposable Pumps
- 15.2.1.5. Large Volume Pumps
- 15.2.1.6. Elastomeric Pumps
- 15.2.2. Infusion Set
- 15.2.3. Accessories
- 15.3. Market Value Forecast, by Indication, 2017-2031
- 15.3.1. Cancer
- 15.3.2. Gastrointestinal Diseases / Disorders
- 15.3.3. Congestive Heart Failure
- 15.3.4. Rheumatoid Arthritis
- 15.3.5. Hemophilia
- 15.3.6. Immune Deficiencies
- 15.3.7. Others
- 15.4. Market Value Forecast, by Therapy Type, 2017-2031
- 15.4.1. Antibiotic/Antiviral
- 15.4.2. Anti-coagulation
- 15.4.3. Anti-emetics
- 15.4.4. Blood Component Stimulating Factor
- 15.4.5. Chemotherapy
- 15.4.6. Nutrition
- 15.4.7. Hydration
- 15.4.8. Pain Management
- 15.5. Market Value Forecast, by End-user, 2017-2031
- 15.5.1. Hospitals
- 15.5.2. Ambulatory Surgical Centers
- 15.5.3. Clinics
- 15.5.4. Homecare Settings
- 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.6.1. GCC Countries
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
- 15.7. Market Attractiveness Analysis
- 15.7.1. By Product
- 15.7.2. By Indication
- 15.7.3. By Therapy Type
- 15.7.4. By End-user
- 15.7.5. By Country/Sub-region
16. Competition Landscape
- 16.1. Market Player - Competition Matrix (by tier and size of companies)
- 16.2. Market Share Analysis, by Company, 2021
- 16.3. Company Profiles
- 16.3.1. B. Braun Melsungen AG
- 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.1.2. Product Portfolio
- 16.3.1.3. Financial Overview
- 16.3.1.4. SWOT Analysis
- 16.3.1.5. Strategic Overview
- 16.3.2. Medtronic plc
- 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.2.2. Product Portfolio
- 16.3.2.3. Financial Overview
- 16.3.2.4. SWOT Analysis
- 16.3.2.5. Strategic Overview
- 16.3.3. Becton, Dickinson and Company
- 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.3.2. Product Portfolio
- 16.3.3.3. Financial Overview
- 16.3.3.4. SWOT Analysis
- 16.3.3.5. Strategic Overview
- 16.3.4. ICU medical (Smiths Medical)
- 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.4.2. Product Portfolio
- 16.3.4.3. Financial Overview
- 16.3.4.4. SWOT Analysis
- 16.3.4.5. Strategic Overview
- 16.3.5. Baxter International, Inc.
- 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.5.2. Product Portfolio
- 16.3.5.3. Financial Overview
- 16.3.5.4. SWOT Analysis
- 16.3.5.5. Strategic Overview
- 16.3.6. Polymedicure
- 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.6.2. Product Portfolio
- 16.3.6.3. Financial Overview
- 16.3.6.4. SWOT Analysis
- 16.3.6.5. Strategic Overview
- 16.3.7. BIO-MED
- 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.7.2. Product Portfolio
- 16.3.7.3. Financial Overview
- 16.3.7.4. SWOT Analysis
- 16.3.7.5. Strategic Overview
- 16.3.8. Terumo Medical Corporation
- 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.8.2. Product Portfolio
- 16.3.8.3. Financial Overview
- 16.3.8.4. SWOT Analysis
- 16.3.8.5. Strategic Overview
- 16.3.9. MEDIPRIM GmbH
- 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.9.2. Product Portfolio
- 16.3.9.3. Financial Overview
- 16.3.9.4. SWOT Analysis
- 16.3.9.5. Strategic Overview
- 16.3.10. Fresenius Kabi
- 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.10.2. Product Portfolio
- 16.3.10.3. Financial Overview
- 16.3.10.4. SWOT Analysis
- 16.3.10.5. Strategic Overview
- 16.3.11. Cardinal Health
- 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.11.2. Product Portfolio
- 16.3.11.3. Financial Overview
- 16.3.11.4. SWOT Analysis
- 16.3.11.5. Strategic Overview